Direkt zum Inhalt
Merck
  • [Non-Hodgkin lymphoma of maxillofacial soft tissue: a report of two cases and review of the literature].

[Non-Hodgkin lymphoma of maxillofacial soft tissue: a report of two cases and review of the literature].

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique (2013-05-15)
S Chaabouni, H Ben Salah Lahiani, L Ghorbel, M Abdelmoula, M Elloumi, J Daoud
ZUSAMMENFASSUNG

The extranodal non-Hodgkin lymphomas of maxillofacial soft tissues are rare. We report two cases of maxillofacial soft tissue non-Hodgkin lymphoma treated with chemotherapy followed by localized radiotherapy with complete remission after 3 and 6 months. We study the clinical, radiological and histopathological features as well as the treatment and the prognosis of extranodal non-Hodgkin lymphomas maxillofacial muscles.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Cyclophosphamid Monohydrat, bulk package
Sigma-Aldrich
Prednison, ≥98%
Sigma-Aldrich
Cyclophosphamid Monohydrat, ISOPAC®
Sigma-Aldrich
Vincristin -sulfat (Salz), 95.0-105.0% (HPLC), powder or crystals
Supelco
Prednison, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Vincristin -sulfat, meets USP testing specifications
Vincristinsulfat, European Pharmacopoeia (EP) Reference Standard